1. Home
  2. SELF vs CTSO Comparison

SELF vs CTSO Comparison

Compare SELF & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Self Storage Inc.

SELF

Global Self Storage Inc.

HOLD

Current Price

$5.05

Market Cap

56.7M

Sector

Real Estate

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.69

Market Cap

45.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELF
CTSO
Founded
1983
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.7M
45.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SELF
CTSO
Price
$5.05
$0.69
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
49.2K
126.1K
Earning Date
11-07-2025
11-13-2025
Dividend Yield
5.86%
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$12,733,279.00
$36,979,520.00
Revenue This Year
$1.59
$9.51
Revenue Next Year
$1.62
$24.40
P/E Ratio
$32.13
N/A
Revenue Growth
3.36
23.89
52 Week Low
$4.73
$0.60
52 Week High
$5.89
$1.61

Technical Indicators

Market Signals
Indicator
SELF
CTSO
Relative Strength Index (RSI) 57.28 47.73
Support Level $4.95 $0.61
Resistance Level $5.18 $0.77
Average True Range (ATR) 0.13 0.06
MACD 0.01 0.00
Stochastic Oscillator 90.91 53.86

Price Performance

Historical Comparison
SELF
CTSO

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: